A Randomised, Placebo Controlled, Double-Blinded Comparative Study Evaluating the Effect of Ramipril on Urinary Protein Excretion in Maintenance Renal Translplant Patients Converted to Sirolimus
Phase of Trial: Phase IV
Latest Information Update: 29 Oct 2014
At a glance
- Drugs Ramipril (Primary) ; Sirolimus
- Indications Renal transplant rejection
- Focus Therapeutic Use
- Sponsors Pfizer
- 01 Sep 2013 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 30 Mar 2013 Planned number of patients changed from 440 to 457 as reported by European Clinical Trials Database.
- 02 Jun 2012 Additional locations added as reported by European Clinical Trials Database record.